Proyectos archivo | Página 12 de 29 | Grupo de investigación en Adicciones a Sustancias

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans Autor: Papaseit E, Olesti E, Pérez-Mañá C, Torrens M, Fonseca F, Grifell M, et al. Revista: Pharmaceuticals (Basel). 2021 Feb 1; 14(2):1–13 Fuente: mdpi.com Volver a...

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users Autor: La Maida N, Papaseit E, Martínez L, Pérez-Mañá C, Poyatos L, Pellegrini M, et al. Revista: Biology (Basel). 2021 Apr 1; 10(4) Fuente:...

Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat

Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat Autor: Moltó J, Bailón L, Pérez-Mañá C, Papaseit E, Miranda C, Martín S, et al. Revista: J Antimicrob Chemother. 2021 Sep 25. Fuente: academic.oup.com Volver a...

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure Autor: Poyatos L, Papaseit E, Olesti E, Pérez-Mañá C, Ventura M, Carbón X, et al. Revista: Biology (Basel). 2021 Aug 1;...

A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I 1-Imidazoline Receptor)

A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I 1-Imidazoline Receptor) Autor: Keller B, Mestre-Pinto JI, Álvaro-Bartolomé M, Martinez-Sanvisens D, Farre M, García-Fuster...

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment Autor: Fuster D, García-Calvo X, Bolao F, Zuluaga P, Rocamora G, Hernández-Rubio A, Sanvisens A, Tor, Muga R Revista: Drug and Alcohol DependenceVolume...

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure

A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I 1-Imidazoline Receptor)

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment

Buscar

Entradas por categoría

Entradas Recientes